BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pathology News - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.pathologynews.com
X-WR-CALDESC:Events for Pathology News
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20240101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20251013T140000
DTEND;TZID=Europe/London:20251013T150000
DTSTAMP:20260829T174147
CREATED:20250929T163601Z
LAST-MODIFIED:20251003T080807Z
UID:100115844-1760364000-1760367600@www.pathologynews.com
SUMMARY:TIA Centre Seminar Series - Towards Multimodal AI for Personalized Cancer Treatment
DESCRIPTION:The Tissue Image Analytics (TIA) Centre hosts a seminar series for those interested in computational pathology. The series invites researchers and leaders in computational pathology and related fields to present their work and foster thought-provoking discussions. \nThe next seminar will take place on Monday\, 13 October\, from 2–3 p.m. UK time. The Centre is delighted to announce that the session will feature Dr. Nadieh Khalili from Radboud UMC\, The Netherlands\, who will be joining online. \nAbstract\nThe integration of diverse data types—such as histopathology\, radiology\, and omics—offers a powerful opportunity to develop AI models that improve cancer diagnosis and treatment selection. In this talk\, I will present recent efforts from our group in developing and validating multimodal deep learning frameworks that predict treatment-relevant biomarkers directly from routine diagnostic images. I will highlight case studies in bladder and prostate cancer and discuss challenges related to data harmonization\, model generalization\, and clinical translation. \nRegister NowBio\nDr Nadieh Khalili is an Assistant Professor in AI at Radboud UMC\, where she leads research at the intersection of deep learning\, digital pathology\, and multi-modal data integration. Her work focuses on developing clinically meaningful AI tools for cancer diagnosis and treatment response prediction. She has a background in biomedical engineering and previously worked in R&D roles in industry. Dr Khalili is also actively involved in organizing scientific events and is a board member of the European Society of Digital Pathology.
URL:https://www.pathologynews.com/event/tia-centre-seminar-series-towards-multimodal-ai-for-personalized-cancer-treatment/
LOCATION:Online
CATEGORIES:Live Online Webinar
ATTACH;FMTTYPE=image/png:https://www.pathologynews.com/wp-content/uploads/2025/09/TIA-Centre-Seminar-Series-Towards-Multimodal-AI-for-Personalized-Cancer-Treatment-.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20251016T160000
DTEND;TZID=Europe/London:20251016T170000
DTSTAMP:20260829T174147
CREATED:20250827T151754Z
LAST-MODIFIED:20250827T152303Z
UID:100115278-1760630400-1760634000@www.pathologynews.com
SUMMARY:Masterclass Webinar: Admin and Metadata Options in HALO Link
DESCRIPTION:0000Days00Hrs00Min00SecLearn how to maximize the efficiency\, customization\, and data management capabilities of your HALO Link deployments!\nSummaryJoin Indica Labs for this Masterclass Webinar designed for system administrators who want to maximize the efficiency\, customization\, and data management capabilities of their HALO Link deployments. This session will provide an in-depth review of the Admin Dashboard\, highlighting tools for managing users\, groups\, and permissions\, and explore the new Diagnostics Monitor tool for troubleshooting image viewing performance bottlenecks.  \n\nThe webinar will also dive into metadata management\, including how to create custom fields that support better data organization. Whether supporting a large research team or managing multi-site deployments\, this session will equip administrators with practical strategies to tailor HALO Link to their needs\, reduce administrative burden\, and empower users to work more efficiently. \n\nLearning Objectives\nLearn about all the functionality in the current Admin Dashboard in HALO Link \nLearn how the new opt-in Diagnostics Monitor feature (available in HALO Link 4.2) provides information for troubleshooting performance bottlenecks with image viewing \nLearn about tools to manage users\, permissions\, and user groups \nLearn about creating and managing system metadata fields  \n\nRegister NowPresentKat Latimer\nHALO Link Associate Product Manager\nIndica Labs  \nKat Latimer earned a ME in Biomedical Engineering from Colorado State University in 2025 and BS in Biochemistry from the University of New Mexico in 2018. Her graduate studies focused on tissue engineering and the use of biomaterials for wound healing. During her undergraduate studies\, Kat participated in several research opportunities including investigating the role of cellular adhesion proteins in HPV oncogene expression.  In 2020 she joined Indica Labs as a Software Quality Assurance Analyst. In 2021 she transitioned to the Product Management team and has since been promoted to the HALO Link Associate Product Manager role where she works closely with the software developers creating new features to improve the user experience. 
URL:https://www.pathologynews.com/event/masterclass-webinar-admin-and-metadata-options-in-halo-link/
LOCATION:Online
CATEGORIES:Live Online Webinar
ATTACH;FMTTYPE=image/png:https://www.pathologynews.com/wp-content/uploads/2025/08/Masterclass-Webinar-Admin-and-Metadata-Options-in-HALO-Link.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20251021T160000
DTEND;TZID=Europe/London:20251021T170000
DTSTAMP:20260829T174148
CREATED:20250827T154822Z
LAST-MODIFIED:20250827T154822Z
UID:100115293-1761062400-1761066000@www.pathologynews.com
SUMMARY:Multi-Omics Analysis Demonstrates Repetitive Head Impacts Induce Neuronal Loss and Neuroinflammation in Young Athletes
DESCRIPTION:0000Days00Hrs00Min00SecLearn how HALO image analysis is helping to advance the understanding of chronic traumatic encephalopathy!\nSummaryRepetitive head impacts (RHI) sustained from contact sports are the largest risk factor for chronic traumatic encephalopathy (CTE). Currently\, CTE can only be diagnosed after death and the multicellular cascade of events that trigger initial hyperphosphorylated tau (p-tau) deposition remain unclear. Further\, the symptoms endorsed by young individuals with early disease are not fully explained by the extent of p-tau deposition\, severely hampering development of therapeutic interventions. Using genomics\, spatial transcriptomics\, and histology it was observed that RHI exposure associates with a multicellular response in young individuals (<51 years old) prior to the onset of CTE p-tau pathology that correlates with number of years of RHI exposure. SPP1+ inflammatory microglia\, angiogenic and inflamed endothelial cell profiles\, reactive astrocytes\, and altered synaptic gene expression in excitatory and inhibitory neurons were identified in all individuals with exposure to RHI. Surprisingly\, elevation in collagen deposition around blood vessels that might be related to long term disease outcomes was also observed. Overall\, these results provide robust evidence that multiple years of RHI exposure is sufficient to induce lasting cellular alterations that may underlie p-tau deposition and help explain the early pathogenesis in young former contact sport athletes. \nLearning Objectives\nUnderstand how HALO image analysis can assist in characterizing pathology in neurodegenerative diseases \nUnderstand how HALO AI can be used to identify unique cell populations with complex\, varied shapes \nExplore how genomic data can be validated using histologic images analysis\n\nRegister NowPresenterJonathan Cherry\, PhD \nResearch Health Scientist \nVA Boston Healthcare System \nDirector\, Digital Pathology Core & Research Neuropathologist \nBoston University Alzheimer’s Disease Research Center and Boston University Chronic Traumatic Encephalopathy Center \nAssistant Professor of Pathology and Laboratory Medicine\nBoston University Avedisian & Chobanian School of Medicine \nDr. Cherry is an Assistant Professor of Pathology and Laboratory Medicine. He completed his undergraduate studies with a BS in biology at Ursinus College in 2008\, earned his doctoral degree in Pathology from the University of Rochester in 2015\, and joined the McKee laboratory as a postdoctoral researcher the same year. He was appointed as an assistant professor at Boston University School of Medicine in 2019. Dr. Cherry also holds a research health scientist position within the VA Boston Healthcare System. His laboratory space is located at the Jamaica Plain VA hospital where he performs his research and helps support the UNITE brain bank.  \nDr. Cherry’s research interests focus on understanding how neuroinflammation after repetitive traumatic brain injury contributes to CTE pathogenesis. Specifically\, Dr. Cherry seeks to identify what role microglia and inflammatory cytokines play in the early onset of hyperphosphorylated tau accumulation and spread.  \nDr. Cherry’s research also extends to histology analysis and machine learning. He is the director of the BU digital pathology core. This research entails exploring novel ways to analyze human postmortem tissue using machine learning algorithms for neuropathologic targets and better characterize pathology across a spectrum of neurodegenerative diseases including Alzheimer’s disease\, chronic traumatic encephalopathy\, frontotemporal lobar degeneration\, motor neuron diseases\, and others. 
URL:https://www.pathologynews.com/event/multi-omics-analysis-demonstrates-repetitive-head-impacts-induce-neuronal-loss-and-neuroinflammation-in-young-athletes/
LOCATION:Online
CATEGORIES:Live Online Webinar
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/08/Multi-Omics-Analysis-Demonstrates-Repetitive-Head-Impacts-Induce-Neuronal-Loss-and-Neuroinflammation-in-Young-Athletes.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20251023T160000
DTEND;TZID=Europe/London:20251023T170000
DTSTAMP:20260829T174148
CREATED:20251019T084830Z
LAST-MODIFIED:20251019T084830Z
UID:100116283-1761235200-1761238800@www.pathologynews.com
SUMMARY:AISight Dx Digital Pathology Platform: Live Deep Dive
DESCRIPTION:0000Days00Hrs00Min00SecJoin PathAI to learn how AISight Dx supports modern pathology workflows at enterprise scale. \nIn this webinar\, PathAI will show how AISight® Dx supports modern digital pathology workflows at scale\, including seamless slide management\, flexible collaboration\, and interoperability across a broad range of whole-slide imaging scanners\, and will explain what PCCP means for ongoing updates and customer value. \nYou’ll also see a live demonstration with case-based examples covering slide navigation\, AISight Live for synchronous and asynchronous collaboration\, annotation tools\, and the caselist dashboard. \nWhat you’ll learn\n\nWhat FDA 510(k) clearance with a PCCP means in practice for AISight Dx and your roadmap\nHow pathologists and lab leaders can standardize workflows\, collaborate across teams\, and stay ready for future feature updates enabled under the PCCP\nLive demo: lightning-fast slide navigation and manipulation\, measurements and annotations\, real-time and asynchronous collaboration with AISight Live\, case list triage\, search\, filters\, and workflow handoffs\n\nRegister Now
URL:https://www.pathologynews.com/event/aisight-dx-digital-pathology-platform-live-deep-dive/
LOCATION:Online
CATEGORIES:Live Online Webinar
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/10/AISight-Dx-Digital-Pathology-Platform-Live-Deep-Dive.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20251027T140000
DTEND;TZID=Europe/London:20251027T150000
DTSTAMP:20260829T174148
CREATED:20251014T133819Z
LAST-MODIFIED:20251014T133819Z
UID:100116188-1761573600-1761577200@www.pathologynews.com
SUMMARY:TIA Centre Seminar Series - Conformal Quantification of Predictive Uncertainty in Health AI
DESCRIPTION:The Tissue Image Analytics (TIA) Centre hosts a seminar series for those interested in computational pathology. The series invites researchers and leaders in computational pathology and related fields to present their work and foster thought-provoking discussions. \nThis seminar features Dr Tapabrata (Rohan) Chakraborty from UCL\, London\, UK. \nAbstract\nFor AI to be trusted for use in high risk applications like healthcare\, it is important to ensure (AI Assurance) that the predictive uncertainty is within guaranteed bounds which can be achieved through conformal prediction based calibration at user defined level of significance. \nRegister NowBio\nRohan is a Theme/Group Lead in Frontier AI Assurance at the Alan Turing Institute and a Principal Research Fellow at UCL Cancer Institute. He leads TRAIL\, the Transparent and Responsible AI Lab shared between UCL/Turing. Rohan is an invited expert in Responsible AI with the Global Partnership on AI and an Editor with Springer Nature Computer Science. Rohan has a PhD in Computer Science and worked as a postdoctoral researcher at the University of Oxford where he continues to an Honorary Fellow of Linacre College and a Lecturer in Computer Science with Christ Church College.
URL:https://www.pathologynews.com/event/tia-centre-seminar-series-conformal-quantification-of-predictive-uncertainty-in-health-ai/
LOCATION:Online
CATEGORIES:Live Online Webinar
ATTACH;FMTTYPE=image/png:https://www.pathologynews.com/wp-content/uploads/2025/10/TIA-Centre-Seminar-Series-Conformal-Quantification-of-Predictive-Uncertainty-in-Health-AI.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20251028T153000
DTEND;TZID=UTC:20251028T163000
DTSTAMP:20260829T174148
CREATED:20250912T085339Z
LAST-MODIFIED:20250912T085339Z
UID:100115449-1761665400-1761669000@www.pathologynews.com
SUMMARY:ACCESS25 - The Future of Precision Medicine Starts at the Moment of Diagnosis
DESCRIPTION:0000Days00Hrs00Min00SecJoin Access25 on October 28 to discover how Proscia is removing one of the biggest barriers to realizing precision medicine — access to the right patients\, at the right moment\, with the right data. \nWith the launch of Proscia Aperture™\, biopharma leaders will discover how to automatically identify trial and treatment candidates at the moment of diagnosis—accelerating recruitment and advancing novel therapies. \nClinical lab leaders will learn how Aperture elevates the lab’s strategic role in the precision medicine ecosystem while creating new revenue streams. \nAnd for everyone attending\, the Partner Expo will feature breakthroughs in pathology AI\, next-generation infrastructure\, and enterprise solutions—delivered by the strongest ecosystem in the industry. \nRegister Now
URL:https://www.pathologynews.com/event/access25-the-future-of-precision-medicine-starts-at-the-moment-of-diagnosis/
LOCATION:Online
CATEGORIES:Live Online Webinar
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/09/The-Future-of-Precision-Medicine-Starts-at-the-Moment-of-Diagnosis.jpg
END:VEVENT
END:VCALENDAR